CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Merck KGaA is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Merck KGaA
Frankfurter Strasse 250
Phone: +49 6151720p:+49 6151720 DARMSTADT, 64293  Germany Ticker: MRKMRK
Business Summary
Merck KGaA is a Germany-based science and technology company. The Company operates in three business segments: Healthcare, Life Sciences and Electronics. The Healthcare business segment is operating in the therapeutic areas of oncology, neurology & immunology and fertility as well as cardiovascular, metabolic and endocrinological disorders. The Life Sciences segment is operating with its three business units such as, Science & Lab Solutions, Process Solutions and Life Science Services. It is also a supplier of products, tools and services for research laboratories, pharmaceutical and biopharmaceutical production as well as industrial and testing laboratories. The Electronics business segment consists of the Semiconductor Solutions, Display Solutions and Surface Solutions business units. Its Semiconductor Solutions business unit consists of the thin films, formulations, specialty gases, and delivery systems & services business fields.
(Source: Company's Website)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-YesYes--

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/202512/31/2025YesYes--Yes

Industries
SIC Code Description
2834 Pharmaceutical preparations
2833 Medicinal chemicals and botanical products
2836 Biological products, except diagnostic substances
3845 Electromedical and electrotherapeutic apparatus
8731 Commercial physical and biological research
3679 Electronic components, not elsewhere classified
2819 Industrial inorganic chemicals, not elsewhere classified
3674 Semiconductors and related devices
5169 Chemicals and allied products, not elsewhere classified
5049 Professional equipment and supplies, not elsewhere classified
3826 Laboratory analytical instruments
5122 Drugs, drug proprietaries, and druggists' sundries

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Independent Chairman of the Supervisory Board MichaelKleinemeier 67 2/13/2024 4/26/2019
Chairman of the Executive Board, Chief Executive Officer BelenGarijo 65 5/1/2021 1/1/2015
Vice Chairman of the Supervisory Board SaschaHeld 42 5/28/2020 4/26/2019
11 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
SIGMA-ALDRICH CANADA LTD
Merck Pte. Ltd. 2 Science Park Dr, #04-01/12 2 Singapore
VERSUM MATERIALS IRELAND LIMITED 3RD FLOOR KILMORE HOUSE PARK LANE IE
72 additional Subsidiary records available in full report.

Business Names
Business Name
0O14
Aldrich Chemical Co. LLC
Aldrich Chemical Foreign Holding LLC
298 additional Business Names available in full report.

General Information
Number of Employees: 62,461 (As of 12/31/2025)
Outstanding Shares: 434,777,877 (As of 12/31/2025)
Shareholders: 334,992
Stock Exchange: ETR
Federal Tax Id: 132666399
Fax Number: +49 6151722000


Copyright © 2026 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Tuesday, March 24, 2026